跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RB-3
首页
药物
RB-3
RB-3
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PHENYL DERIVATIVES SUBSTITUTED WITH AT LEAST TWO ELECTRON ACCEPTORS AND AT LEAST TWO ELECTRON DONORS FOR USE IN ORGANIC ELECTRONIC DEVICES
EP 3325442 A1
申请人: MERCK PATENT GMBH
优先权: 2015
CN
EP
US
WO
5 件公开
Pyrrolinone derivative and pharmaceutical composition comprising the same
US 8101644 B2
申请人: KAI HIROYUKI
优先权: 2007
CN
US
5 件公开
Use of an adrenal hormone-modifying agent
US 8609862 B2
申请人: HU QI-YING
优先权: 2010
CN
US
4 件公开
Liquid crystal compound having lactone ring, liquid crystal composition, and liquid crystal display device
US 7618688 B2
申请人: CHISSO CORP
优先权: 2005
US
4 件公开
Morpholinopurine derivatives
US 8097622 B2
申请人: NAKAYAMA KIYOSHI
优先权: 2008
US
4 件公开
METHOD FOR PRODUCING BENZOXAZOLE DERIVATIVE HAVING BICYCLIC PIPERAZINE RING OR SALT THEREOF, AND METHOD FOR PRODUCING MATERIAL THEREOF
US 2024309010 A1
申请人: MEIJI SEIKA PHARMA CO LTD
优先权: 2021
CN
US
WO
3 件公开
METHOD FOR PRODUCING ALKYLSILYLOXY-SUBSTITUTED BENZYLAMINE COMPOUND
US 20260176238 A1
申请人: SEKISUI MEDICAL CO LTD
优先权: 2022
CN
US
WO
3 件公开
NOVEL IMIDAZOLIDINE DERIVATIVE AND USE THEREOF
US 2011306615 A1
申请人: TACHIBANA KAZUTAKA
优先权: 2004
CN
US
3 件公开
Contrast agents
US 8323619 B2
申请人: MORISSON-IVESON VERONIQUE
优先权: 2007
CN
US
3 件公开
Methods of peptide modification
US 9212202 B2
申请人: STENSEN WENCHE
优先权: 2007
CN
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈